AgeX Therapeutics SG&A Expense (TTM) Analysis

AgeX Therapeutics Inc (DELISTED) (AGE:DL)

11.10 -1.50 (-11.90%) USD | NYAM | Mar 26, 16:00

12.18 +1.08 (+9.73%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2023	7.476M
June 30, 2023	6.696M
March 31, 2023	6.304M
December 31, 2022	5.971M
September 30, 2022	5.907M
June 30, 2022	5.936M
March 31, 2022	6.346M
December 31, 2021	6.708M
September 30, 2021	6.766M
June 30, 2021	7.141M

Date	Value
March 31, 2021	6.868M
December 31, 2020	6.721M
September 30, 2020	6.863M
June 30, 2020	7.261M
March 31, 2020	7.905M
December 31, 2019	8.139M
September 30, 2019	8.39M
June 30, 2019	7.45M
March 31, 2019	6.466M
December 31, 2018	5.647M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

5.907M

Minimum

Sep 2022

8.39M

Maximum

Sep 2019

6.936M

Average

6.814M

Median

SG&A Expense (TTM) Benchmarks